Polomar Health Services (PMHS) 10-Q 15 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 08, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-56555
Entity Registrant Name	Trustfeed Corp.
Entity Central Index Key	0001265521
Entity Tax Identification Number	86-1006313
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	140 Broadway
Entity Address, Address Line Two	46th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10005
City Area Code	800
Local Phone Number	490-7454
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		109,138,049

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 15,084	$ 225,619
Accounts receivable		30,000
Prepaid expenses		5,865
Due from related party	113,882	0
Total current assets	128,966	261,484
Total assets	128,966	261,484
Current liabilities
Accounts payable and accrued liabilities	10,212	5,012
Due to related party	4,699	69,703
Total current liabilities	14,911	74,715
Total liabilities	14,911	74,715
Stockholders' deficit
Preferred stock, par value $0.001; 500,000 shares authorized; 500,000 and 500,000 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.	500	500
Common stock; $0.001 par value; 295,000,000 shares authorized; 109,138,049 and 107,582,614 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.	109,138	107,582
Additional paid-in capital	1,275,156	1,023,476
Stock payable		37,044
Accumulated deficit	(1,270,739)	(981,833)
Total stockholders' deficit	114,055	186,769
Total liabilities and stockholders' deficit	$ 128,966	$ 261,484

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022	Nov. 04, 2022
Statement of Financial Position [Abstract]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	500,000	500,000
Preferred Stock, Shares Issued	500,000	500,000
Preferred Stock, Shares Outstanding	500,000	500,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001	$ 0.001
Common Stock, Shares Authorized	295,000,000	295,000,000
Common Stock, Shares, Issued	109,138,049	107,582,614
Common Stock, Shares, Outstanding	109,138,049	107,582,614

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue		$ 4,526		$ 4,526
Cost of Good Sold
Gross Profit		4,526		4,526
Operating expenses
General and administrative	70,657	18,044	251,421	34,002
Total operating expenses	70,657	18,044	251,421	34,002
Loss from operations	(70,657)	(13,518)	(251,421)	(29,476)
Other expense
Foreign currency gain (loss)	(53)	77	(53)	77
Forgiveness of receivable - related party	(37,432)		(37,432)
Total other income (expense)	(37,485)	77	(37,485)	77
Net loss	$ (108,142)	$ (13,441)	$ (288,906)	$ (29,399)
Net loss per common share: basic and diluted	$ 0	$ (0.05)	$ 0	$ (0.10)
Basic weighted average common shares outstanding	108,166,142	266,157	107,726,216	292,430

STATEMENTS OF STOCKHOLDERS' DEF

STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock Payable [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 50,000	$ 314	$ 714,749		$ (800,709)	$ (35,646)
Shares, Issued at Dec. 31, 2021	50,000,000	313,577
Net loss					(2,250)	(2,250)
Ending balance, value at Mar. 31, 2022	$ 50,000	$ 314	714,749		(802,959)	(37,896)
Shares, Issued at Mar. 31, 2022	50,000,000	313,577
Beginning balance, value at Dec. 31, 2021	$ 50,000	$ 314	714,749		(800,709)	(35,646)
Shares, Issued at Dec. 31, 2021	50,000,000	313,577
Net loss						(29,399)
Ending balance, value at Sep. 30, 2022	$ 50,000	$ 309	714,754		(830,108)	(65,045)
Shares, Issued at Sep. 30, 2022	50,000,000	308,827
Beginning balance, value at Mar. 31, 2022	$ 50,000	$ 314	714,749		(802,959)	(37,896)
Shares, Issued at Mar. 31, 2022	50,000,000	313,577
Net loss					(13,708)	(13,708)
Return and cancellation of common stock		$ (5)	5
[custom:ReturnAndCancellationOfCommonStockDuringPeriodShares]		(4,750)
Ending balance, value at Jun. 30, 2022	$ 50,000	$ 309	714,754		(816,667)	(51,604)
Shares, Issued at Jun. 30, 2022	50,000,000	308,827
Net loss					(13,441)	(13,441)
Ending balance, value at Sep. 30, 2022	$ 50,000	$ 309	714,754		(830,108)	(65,045)
Shares, Issued at Sep. 30, 2022	50,000,000	308,827
Beginning balance, value at Dec. 31, 2022	$ 500	$ 107,582	1,023,476	37,044	(981,833)	186,769
Shares, Issued at Dec. 31, 2022	500,000	107,582,614
Common stock issued for cash		$ 936	139,395	(30,139)		110,192
Stock Issued During Period, Shares, Other		935,365
Net loss					(89,806)	(89,806)
Ending balance, value at Mar. 31, 2023	$ 500	$ 108,518	1,162,871	6,905	(1,071,639)	207,155
Shares, Issued at Mar. 31, 2023	500,000	108,517,979
Beginning balance, value at Dec. 31, 2022	$ 500	$ 107,582	1,023,476	37,044	(981,833)	186,769
Shares, Issued at Dec. 31, 2022	500,000	107,582,614
Net loss						(288,906)
Ending balance, value at Sep. 30, 2023	$ 500	$ 109,138	1,275,156		(1,270,739)	114,055
Shares, Issued at Sep. 30, 2023	500,000	109,138,049
Beginning balance, value at Mar. 31, 2023	$ 500	$ 108,518	1,162,871	6,905	(1,071,639)	207,155
Shares, Issued at Mar. 31, 2023	500,000	108,517,979
Common stock issued for cash		$ 47	6,858	(6,905)
Stock Issued During Period, Shares, Other		46,900
Net loss					(90,958)	(90,958)
Ending balance, value at Jun. 30, 2023	$ 500	$ 108,565	1,169,729		(1,162,597)	116,197
Shares, Issued at Jun. 30, 2023	500,000	108,564,879
Common stock issued for cash		$ 573	105,427			106,000
Stock Issued During Period, Shares, Other		573,170
Net loss					(108,142)	(108,142)
Ending balance, value at Sep. 30, 2023	$ 500	$ 109,138	$ 1,275,156		$ (1,270,739)	$ 114,055
Shares, Issued at Sep. 30, 2023	500,000	109,138,049

STATEMENTS OF CASH FLOWS (Unaud

STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities
Net loss	$ (288,906)	$ (29,399)
Adjustments to reconcile net loss to net cash provided by operating activities:
Bad debt	20,000
Forgiveness of receivable - related aprty	37,432
Changes in assets and liabilities
Accounts receivable	10,000
Prepaid expenses	5,865
Due from related party	(151,314)
Accounts payable	5,200	4,078
Net cash used in operating activities	(361,723)	(25,321)
Cash Flows from Financing Activities
Proceeds from the issuance of common stock	216,192
Proceeds from related party debt	2,564	29,925
Payment of related party debt	(67,568)
Net cash from financing activities	151,188	29,925
Net increase (decrease) in cash	(210,535)	4,604
Cash, beginning of period	225,619
Cash, end of period	15,084	4,604
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for taxes
Non-Cash investing and financing transactions
Return and cancellation of common stock		$ 95,000

NOTE 1 _ NATURE AND DESCRIPTION

NOTE 1 – NATURE AND DESCRIPTION OF BUSINESS	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
NOTE 1 – NATURE AND DESCRIPTION OF BUSINESS	NOTE 1 – NATURE AND DESCRIPTION OF BUSINESS HealthMed Services, Ltd. the (“the Company”) was incorporated in the State of Nevada September 14, 2000 On April 16, 2021, a board member agreed to sell, assign, and transfer 4,850,000 45,000,000 On April 27, 2021, James Shipley resigned as President, Secretary, Treasurer, and Director of the Company at which time Rasmus Refer was appointed to these positions. On September 23, 2022 the Company changed its name to Trustfeed Corp. and its ticker to TRFE. Trustfeed is a technology company with access to a global database of company information. Trustfeed offers software-as-aservice (“SaaS”) based applications and services to its business and consumer customers. Trustfeed believes that trust is the foundation of the buyer digital journey. Consumers are jaded by the ‘wild west’ approach to reviews and company information and want the reassurance that the information they are reading is from a reliable authority. Proprietary State-of-the-art crawler technology, machine learning and Artificial intelligence tools are the techniques behind Trustfeed’s trustworthy information. Trustfeed introduced a flexible, modular subscription model where businesses can use Trustfeed’s basic services for free and will be able to subscribe for additional paid services on Trustfeed’s platform. Extended options will be added for companies to access their profile and contribute additional useful information, org charts, product information and contact points for additional fees.

NOTE 2 - SUMMARY OF SIGNIFICANT

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the OTC Markets alternative reporting standard for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management's opinion, however, that all material adjustments (consisting of normal and recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Use of estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates. Cash and cash equivalents For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022. Stock-based compensation The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. Earnings per share The Company follows ASC Topic 260 to account for the earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. Revenue recognition We recognize revenue in accordance with generally accepted accounting principles as outlined in the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue From Contracts with Customers, which requires that five basic criteria be met before revenue can be recognized: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation. Revenue recognition occurs at the time product is shipped to customers, when control transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. We only record revenue when collectability is probable. Fair value of financial instruments The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are: Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 - Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. Level 3 - Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date. The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of September 30, 2023 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable to related parties approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements at September 30, 2023 and December 31, 2022. Financial assets and liabilities measured at fair value on a recurring basis are summarized below as of September 30, 2023: Level 1 Level 2 Level 3 Total Liabilities Derivative Financial Instruments $ — $ — $ — $ — Financial assets and liabilities measured at fair value on a recurring basis are summarized below as of December 31, 2022: Level 1 Level 2 Level 3 Total Liabilities Derivative Financial Instruments $ — $ — $ — $ —

NOTE 3 - GOING CONCERN

NOTE 3 - GOING CONCERN	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NOTE 3 - GOING CONCERN	NOTE 3 - GOING CONCERN The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Management evaluated all relevant conditions and events that are reasonably known or reasonably knowable, in the aggregate, as of the date the consolidated financial statements are issued and determined that substantial doubt exists about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent on the Company’s ability to generate revenues and raise capital. The Company has not generated any revenues to provide sufficient cash flows to enable the Company to finance its operations internally. As of September 30, 2023, the Company had $15,084 $1,270,739 $288,906 $361,723 Over the next twelve months management plans to raise additional capital and to invest its working capital resources in sales and marketing in order to increase the distribution and demand for its products. However, there is no guarantee the Company will generate sufficient revenues or raise capital to continue operations. If the Company fails to generate sufficient revenue and obtain additional capital to continue at its expected level of operations, the Company may be forced to scale back or discontinue its sales and marketing efforts. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Recent accounting pronouncements Company management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

NOTE 4 _ RELATED PARTY TRANSACT

NOTE 4 – RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
NOTE 4 – RELATED PARTY TRANSACTIONS	NOTE 4 – RELATED PARTY TRANSACTIONS Due from related party During the nine months ended September 30, 2023 the Company made advances to a shareholder totaling $40,000 $2,568 $37,432 During the nine months ended September 30, 2023 the Company made advances to a company commonly controlled by a director of the Company totaling $113,882 0% As of September 30, 2023, and December 31, 2022, the Company had amounts due from related party of $113,882 $0 Due to related party During the nine months ended September 30, 2023, the Company borrowed $2,564 from a shareholder for payment of operating expenses and repaid $67,568 of advances to the same shareholder. The advances have 0% interest and are due upon demand. As of June 30, 2023, and December 31, 2022, the Company had amounts due to related party of $6,360 and $69,703 respectively.

NOTE 5 _ STOCKHOLDERS_ DEFICIT

NOTE 5 – STOCKHOLDERS’ DEFICIT	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
NOTE 5 – STOCKHOLDERS’ DEFICIT	NOTE 5 – STOCKHOLDERS’ DEFICIT The Company is authorized to issue 295,000,000 $0.001 $0.001 1,000,000,000 295,000,000 On June 3, 2022, the Board authorized the execution of a reverse split of the issued and outstanding shares of the Corporation’s common stock at a ratio of up to one post-split share per two thousand pre-split shares (1:2,000) at a time and exact ratio amount the Board of Directors deems appropriate. On September 2, 2022, FINRA approved a 1-for-2,000 reverse stock split of the Company’s common stock that was approved by the Company’s Board of Directors. 109,138,049 107,582,614 The Company also has 500,000 $0.001 500,000 $0.001 50,000,000 500,000 Each share of Series A Preferred Stock is convertible, at any time, at the option of the holder into fully paid and nonassessable shares of common stock at the rate of 20 shares of common stock for each share held. In addition, the holders of the Series A Preferred have voting rights equal to 20 votes for each Preferred share held 500,000 500,000 On November 4, 2022, Trustfeed filed Certificates of Withdrawal in Nevada to withdraw the Certificates of Designation for Series B Preferred Stock and Series C Preferred Stock. Following the transaction, the only designated and outstanding shares of preferred. stock are the company’s Series A Preferred Stock. No shares of Series B Preferred stock or Series C Preferred Stock are issued and outstanding. During the nine months ended September 30, 2023 the Company issued 1,555,435 $253,236 $37,044

NOTE 6 _ SUBSEQUENT EVENTS

NOTE 6 – SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
NOTE 6 – SUBSEQUENT EVENTS	NOTE 6 – SUBSEQUENT EVENTS In accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to September 30, 2023, to the date these financial statements were available to be issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

NOTE 2 - SUMMARY OF SIGNIFICA_2

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the OTC Markets alternative reporting standard for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management's opinion, however, that all material adjustments (consisting of normal and recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year.
Use of estimates	Use of estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Stock-based compensation	Stock-based compensation The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized.
Earnings per share	Earnings per share The Company follows ASC Topic 260 to account for the earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.
Revenue recognition	Revenue recognition We recognize revenue in accordance with generally accepted accounting principles as outlined in the Financial Accounting Standard Board’s (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue From Contracts with Customers, which requires that five basic criteria be met before revenue can be recognized: (i) identify the contract with the customer; (ii) identity the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price; and (v) recognize revenue when or as the entity satisfied a performance obligation. Revenue recognition occurs at the time product is shipped to customers, when control transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. We only record revenue when collectability is probable.
Fair value of financial instruments	Fair value of financial instruments The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are: Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 - Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. Level 3 - Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date. The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of September 30, 2023 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable to related parties approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements at September 30, 2023 and December 31, 2022. Financial assets and liabilities measured at fair value on a recurring basis are summarized below as of September 30, 2023: Level 1 Level 2 Level 3 Total Liabilities Derivative Financial Instruments $ — $ — $ — $ — Financial assets and liabilities measured at fair value on a recurring basis are summarized below as of December 31, 2022: Level 1 Level 2 Level 3 Total Liabilities Derivative Financial Instruments $ — $ — $ — $ —

NOTE 3 - GOING CONCERN (Policie

NOTE 3 - GOING CONCERN (Policies)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recent accounting pronouncements	Recent accounting pronouncements Company management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

NOTE 2 - SUMMARY OF SIGNIFICA_3

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Level 1 Level 2 Level 3 Total Liabilities Derivative Financial Instruments $ — $ — $ — $ — Financial assets and liabilities measured at fair value on a recurring basis are summarized below as of December 31, 2022: Level 1 Level 2 Level 3 Total Liabilities Derivative Financial Instruments $ — $ — $ — $ —

NOTE 2 - SUMMARY OFSIGNIFICANT

NOTE 2 - SUMMARY OFSIGNIFICANT ACCOUNTING POLICIES - Fair Value of Financial Instruments (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]
Derivative Financial Instruments
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto-Asset [Line Items]
Derivative Financial Instruments
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto-Asset [Line Items]
Derivative Financial Instruments
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
Derivative Financial Instruments

NOTE 1 _ NATURE AND DESCRIPTI_2

NOTE 1 – NATURE AND DESCRIPTION OF BUSINESS (Details Narrative) - shares		9 Months Ended
	Apr. 16, 2021	Sep. 30, 2023
Entity Incorporation, State or Country Code		NV
Entity Incorporation, Date of Incorporation		Sep. 14, 2000
Preferred Stock [Member] | Series A Preferred Stock [Member]
Stock Repurchased During Period, Shares	4,850,000
Treasury Stock, Shares, Acquired	45,000,000

NOTE 3 - GOING CONCERN (Details

NOTE 3 - GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 15,084						$ 15,084		$ 225,619
Retained Earnings (Accumulated Deficit)	1,270,739						1,270,739		$ 981,833
Net Income (Loss) Attributable to Parent	$ 108,142	$ 90,958	$ 89,806	$ 13,441	$ 13,708	$ 2,250	288,906	$ 29,399
Net Cash Provided by (Used in) Operating Activities							$ 361,723	$ 25,321

NOTE 4 _ RELATED PARTY TRANSA_2

NOTE 4 – RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Repayments of Related Party Debt				$ (67,568)
Debt Instrument, Decrease, Forgiveness	$ 37,432	$ 37,432		37,432
Loans and Leases Receivable, Related Parties	$ 113,882	$ 113,882		113,882		$ 0
Shareholder Advance [Member]
Related Party Transaction [Line Items]
Payments for Advance to Affiliate				40,000
Repayments of Related Party Debt				2,568
Director Affiliate Advance [Member]
Related Party Transaction [Line Items]
Payments for Advance to Affiliate				$ 113,882
Debt Instrument, Interest Rate During Period				0%

NOTE 5 _ STOCKHOLDERS_ DEFICIT

NOTE 5 – STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)		3 Months Ended			9 Months Ended	12 Months Ended
	Jun. 03, 2022	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Nov. 04, 2022	Nov. 03, 2022
Class of Stock [Line Items]
Common Stock, Shares Authorized		295,000,000			295,000,000	295,000,000
Common Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001	$ 0.001	$ 0.001
Stockholders' Equity, Reverse Stock Split	On June 3, 2022, the Board authorized the execution of a reverse split of the issued and outstanding shares of the Corporation’s common stock at a ratio of up to one post-split share per two thousand pre-split shares (1:2,000) at a time and exact ratio amount the Board of Directors deems appropriate. On September 2, 2022, FINRA approved a 1-for-2,000 reverse stock split of the Company’s common stock that was approved by the Company’s Board of Directors.
Common Stock, Shares, Issued		109,138,049			109,138,049	107,582,614
Common Stock, Shares, Outstanding		109,138,049			109,138,049	107,582,614
Preferred Stock, Shares Authorized		500,000			500,000	500,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001	$ 0.001
Preferred Stock, Shares Issued		500,000			500,000	500,000
Preferred Stock, Shares Outstanding		500,000			500,000	500,000
Stock Issued During Period, Value, Other		$ 106,000		$ 110,192
Issued For Cash [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Other					1,555,435
Stock Issued During Period, Value, Other					$ 253,236
[custom:ProceedsFromIssuanceOfCommonStockPreviouslyReceived]						$ 37,044
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Conversion Basis					Each share of Series A Preferred Stock is convertible, at any time, at the option of the holder into fully paid and nonassessable shares of common stock at the rate of 20 shares of common stock for each share held. In addition, the holders of the Series A Preferred have voting rights equal to 20 votes for each Preferred share held
Preferred Stock, Shares Issued		500,000			500,000	500,000
Preferred Stock, Shares Outstanding		500,000			500,000	500,000
Previous Authorized Shares [Member]
Class of Stock [Line Items]
Common Stock, Shares Authorized								1,000,000,000
Preferred Stock, Shares Authorized								50,000,000
Authorized Shares Post Reduction [Member]
Class of Stock [Line Items]
Common Stock, Shares Authorized							295,000,000
Preferred Stock, Shares Authorized							500,000